New biologic helps those with PI help themselves

Article

Until now, patients with primary immunodeficiency (PI) were treated with intravenous immunoglobulin (IVIg) infusions, which were inconvenient and associated with serious adverse side effects, such as migraine headaches.

Recent Videos
© 2024 MJH Life Sciences

All rights reserved.